DEA vs. Georgia: Tensions Rise Over Medical Cannabis Access As State Regulators Consider Legal Action

The Georgia Access to Medical Cannabis Commission (GMCC) recently convened a special meeting to discuss the ramifications of warning letters received from the U.S. Drug Enforcement Administration (DEA). These letters, directed at pharmacies involved in the state's medical marijuana program, cautioned against dispensing THC.

See Also: Federally Funded Study Shows Delta-8 THC Use Rises In States Where Marijuana Remains Illegal

DEA Caution Raises Concerns For Access To MMJ

The DEA's cautionary messages prompted concerns among officials about potential obstacles to expanding medical marijuana access for Georgia's patients.

Despite the challenges, the Georgia Access to Medical Cannabis Commission (GMCC) maintains its commitment to prioritizing safe access to medical marijuana, reported Marijuana Moment.

“I want patients to know that we are well on our way to fully implementing the Hope Act [Harnessing Opportunities by Pursuing Expungement Act],” GMCC chair Sid Johnson said. “We will continue to pursue our mission of ensuring access to medical cannabis for all patients across Georgia.”

Georgia's approach involved distributing medical marijuana through existing pharmacies, marking the state as a trailblazer. The initiative garnered significant interest, with over 120 independent pharmacies applying to participate in the program.

Legal Considerations And Potential Litigation

Discussions behind the scenes explored the potential for legal action in response to the DEA letters.

Highlighting the need for collaboration with sister agencies, GMCC’s general counsel, Jansen Head, stated: “Any kind of action that we would take are things that we would do through the arms of the AG [state attorney general]’s office, through the executive branch.”

See Also: DEA Cracks Down On Synthetic Cannabinoids, Classifies These Six As Schedule I Drugs

Budget Rider Impact

A budget rider, passed by Congress to prevent the U.S. Department of Justice (DOJ) from intervening in state medical marijuana laws, restricts federal law enforcement “from taking legal action against the states directly to prevent us from promulgating or enforcing our medical marijuana laws," Head added.

Andrew Turnage, the executive director of GMCC, emphasized that the conflict underscores "the need for [the] federal government to update the laws and policies regarding the use of cannabis."

Notable licensed marijuana producers in the state include Botanical Sciences LLC and Trulieve Cannabis Corp. TCNNF.

Read Next: EXCLUSIVE: ATB Capital Markets Signals 2024 Hidden Gems In Canadian Cannabis

Image by El Planteo